These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6244561)

  • 21. Differentiation of F9 embryonal carcinoma cells by synthetic retinoids: amplitude of plasminogen activator production does not depend on retinoid potency or affinity for F9 nuclear retinoic acid receptors.
    Bailly J; Delescluse C; Bernardon JM; Charpentier B; Martin B; Pilgrim WR; Shroot B; Darmon M
    Skin Pharmacol; 1990; 3(4):256-67. PubMed ID: 1964567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible effects of dibutyryl cAMP on laminin and type IV collagen secretion from retinoic acid treated F9 cells.
    Morita A; Kitagawa Y; Sugimoto E
    J Cell Physiol; 1985 Nov; 125(2):263-72. PubMed ID: 2997239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of the clonal growth and differentiation of feeder layer dependent mouse embryonal carcinoma cells by beta-mercaptoethanol.
    Oshima R
    Differentiation; 1978; 11(3):149-55. PubMed ID: 720785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of fetomodulin and tissue plasminogen activator to characterize parietal endoderm differentiation of F9 embryonal carcinoma cells.
    Imada S; Yamaguchi H; Imada M
    Dev Biol; 1990 Oct; 141(2):426-30. PubMed ID: 1698671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of extracellular matrix and growth arrest on the alkaline phosphatase activity of F9 embryonal carcinoma cells.
    Fleming JV; Hay SM; Rees WD
    Biochem Soc Trans; 1996 May; 24(2):221S. PubMed ID: 8736879
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of pulsed electromagnetic field on growth and differentiation of embryonal carcinoma cells.
    Akamine T; Muramatsu H; Hamada H; Sakou T
    J Cell Physiol; 1985 Aug; 124(2):247-54. PubMed ID: 3900096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of retinoic acid and retinol during differentiation of F9 embryonal carcinoma cells.
    Williams JB; Napoli JL
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4658-62. PubMed ID: 3860815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The growth and morphological characteristics of undifferentiated and differentiated cells of the F9 mouse teratocarcinoma line].
    Kisliakova TV; Pospelova TV; Pospelov VA
    Tsitologiia; 1990; 32(1):54-60. PubMed ID: 1973862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A variant F9 embryonal carcinoma cell line which undergoes incomplete differentiation in retinoic acid.
    Moore EE; Moritz EA; Mitra NS
    Cancer Res; 1985 Sep; 45(9):4387-96. PubMed ID: 2992778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
    Linder S; Krondahl U; Sennerstam R; Ringertz NR
    Exp Cell Res; 1981 Apr; 132(2):453-60. PubMed ID: 7215454
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitative switch in integrin expression accompanies differentiation of F9 cells treated with retinoic acid.
    Burdsal CA; Lotz MM; Miller J; McClay DR
    Dev Dyn; 1994 Dec; 201(4):344-53. PubMed ID: 7894073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell proliferation and expression of cytokeratin filaments in F9 embryonal carcinoma cells.
    Kurki P; Laasonen A; Tan EM; Lehtonen E
    Development; 1989 Aug; 106(4):635-40. PubMed ID: 2485243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance and use of F9 teratocarcinoma cells.
    Darrow AL; Rickles RJ; Strickland S
    Methods Enzymol; 1990; 190():110-7. PubMed ID: 1964999
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the relation of DNA synthesis to retinoic acid-induced differentiation of F9 teratocarcinoma cells.
    Griep AE; DeLuca HF
    Exp Cell Res; 1986 May; 164(1):223-31. PubMed ID: 3956593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation-defective mutants of mouse embryonal carcinoma cells: response to hexamethylenebisacetamide and retinoic acid.
    McCue PA; Matthaei KI; Taketo M; Sherman MI
    Dev Biol; 1983 Apr; 96(2):416-26. PubMed ID: 6299821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoic acid, dibutyryl-cAMP, and differentiation affect the expression of retinoic acid receptors in F9 cells.
    Martin CA; Ziegler LM; Napoli JL
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4804-8. PubMed ID: 2162058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of laminin and fibronectin in endodermal and neural differentiation of F9 embryonal carcinoma cells.
    Wartiovaara J; Liesi P; Rechardt L
    Prog Clin Biol Res; 1984; 151():233-47. PubMed ID: 6473367
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclic adenosine monophosphate-mediated induction of F9 teratocarcinoma differentiation in the absence of retinoic acid.
    Goldstein B; Rogelj S; Siegel S; Farmer SR; Niles RM
    J Cell Physiol; 1990 May; 143(2):205-12. PubMed ID: 1692026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in cell-surface N-acetylglucosaminide beta (1----4)galactosyltransferase activity with retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
    Nakhasi HL; Nagarajan L; Anderson WB
    FEBS Lett; 1984 Mar; 168(2):222-6. PubMed ID: 6427003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific growth stimulation in the absence of specific cellular adhesion in lung colonization by retinoic-acid-treated F9 teratocarcinoma cells.
    Rusciano D; Lorenzoni P; Burger MM
    Int J Cancer; 1992 Sep; 52(3):471-7. PubMed ID: 1399123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.